Oncogene‐, tumor‐suppressor‐loss‐, or therapy‐provoked senescence within cancers termed cancer‐cell autonomous senescence is likewise maintained by p53/p16INK4a/p19ARF signaling and reshapes the microenvironment via the SASP [453]. The gene discussed is CDKN2A; the disease is cancer.